Abstract | OBJECTIVE: METHODS: The expression levels of miR-21, miR-24, miR-34a, miR-106a, miR-143, and miR-145 were measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR). RESULTS: The expression of microRNAs was measured by qRT-PCR in a Hiroshima University Hospital cohort comprising 32 patients in the high-dose-exposed group and 18 patients in the low-dose-exposed group who developed GC after the bombing. The GC cases showing high expression of miR-24, miR-143, and miR-145 were more frequently found in the high-dose-exposed group than in the low-dose-exposed group. We next performed qRT-PCR of miR-24, miR-143, and miR-145 in a cohort from the Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital comprising 122 patients in the high-dose-exposed group and 48 patients in the low-dose-exposed group who developed GC after the bombing. High expressions of miR-24 and miR-143 were more frequently found in the high-dose-exposed group than in the low-dose-exposed group. Multivariate analysis demonstrated that only high expression of miR-24 was an independent predictor for the exposure status. CONCLUSION: These results suggest that the measurement of miR-24 expression from FFPE samples is useful to identify radiation-associated GC.
|
Authors | Yutaka Naito, Naohide Oue, Trang T B Pham, Manabu Yamamoto, Megumu Fujihara, Teruyoshi Ishida, Shoichiro Mukai, Kazuhiro Sentani, Naoya Sakamoto, Eisuke Hida, Hiroki Sasaki, Wataru Yasui |
Journal | Pathobiology : journal of immunopathology, molecular and cellular biology
(Pathobiology)
Vol. 82
Issue 2
Pg. 68-75
( 2015)
ISSN: 1423-0291 [Electronic] Switzerland |
PMID | 26045155
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- MIRN24 microRNA, human
- MicroRNAs
|
Topics |
- Adult
- Aged
- Biomarkers
- Female
- Humans
- Male
- MicroRNAs
(genetics)
- Middle Aged
- Neoplasms, Radiation-Induced
(genetics)
- Nuclear Weapons
- Real-Time Polymerase Chain Reaction
- Retrospective Studies
- Stomach Neoplasms
(genetics)
- Survivors
|